Measles Misinformation Is on the Rise — And Americans Are Hearing It, Survey Finds
Attitudes about a debunked link between measles vaccines and autism haven’t budged that much. But there’s a sharp partisan divide over whether the vaccine is safe.
Showing 21 - 40 of 110
-
-
Trump HHS Eliminates Office That Sets Poverty Levels Tied to Benefits for at Least 80 Million People
Recent cuts eliminated a small, specialized workforce that sets the poverty standards determining who is eligible for Medicaid as well as assistance with food, home heating, child care, and more.
By Arthur Allen -
What’s Lost: Trump Whacks Tiny Agency That Works To Make the Nation’s Health Care Safer
The Agency for Healthcare Research and Quality has helped improve health care safety in a country where thousands die of medical errors each year. It was effectively dissolved Tuesday.
By Arthur Allen -
Scientists Say NIH Officials Told Them To Scrub mRNA References on Grants
Two senior scientists say National Institutes of Health officials advised them to remove references to mRNA vaccines in grant applications, and they fear the Trump administration will abandon a promising field of medical research.
By Arthur Allen -
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of the U.S. economy, he would have to engage in the thorny challenges of governing.
By Arthur Allen -
With RFK Jr. in Charge, Supplement Makers See Chance To Cash In
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion industry. Get ready for even less regulation.
By Arthur Allen -
The Covid ‘Contrarians’ Are in Power. We Still Haven’t Hashed Out Whether They Were Right.
Jay Bhattacharya, nominated to lead the National Institutes of Health, opposed most covid mandates. Without an honest public debate about what worked and what didn’t, public health experts say, we’re even less prepared for the next pandemic.
By Arthur Allen -
-
What RFK Jr. Might Face in His Nomination Hearings This Week
Two Senate committees are expected to question Robert F. Kennedy Jr. on how his disproven views of science and medicine qualify him to run the $1.7 trillion, 80,000-employee federal health system.
By Arthur Allen -
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” PBMs — or force them to change.
By Arthur Allen -
How Measles, Whooping Cough, and Worse Could Roar Back on RFK Jr.’s Watch
Inoculation campaigns that protect children and adults from dangerous diseases rely on a delicate web of state and federal laws and programs. If senior officials cast doubt on vaccine safety, the whole system might collapse, especially in red states.
By Arthur Allen -
Scientists Fear What’s Next for Public Health if RFK Jr. Is Allowed To ‘Go Wild’
As federal health scientists await a potential takeover by RFK Jr. and other medical skeptics in the second Trump administration, some are preparing résumés or retirement papers.
By Arthur Allen -
What’s at Stake: A Pivotal Election for Six Big Health Issues
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.
-
-
Helene and CVS Land Double Whammy for 25,000 Patients Who Survive on IV Nutrition
A Massachusetts woman ended up stranded in the hospital because CVS stopped providing the IV nutrition she needs to survive at home. Without it, she’d starve.
By Arthur Allen -
Employers Haven’t a Clue How Their Drug Benefits Are Managed
The Big Three pharmacy benefit managers say they return nearly all the rebates they get from drugmakers to the employers and insurers who hire them. But most employers seem to doubt that.
By Arthur Allen -
FDA’s Promised Guidance on Pulse Oximeters Unlikely To End Decades of Racial Bias
For decades, the pulse oximeters used in hospitals, ambulances, and homes have underestimated the oxygen needs of darker-skinned patients. The FDA is preparing guidelines to fix that. But will the new rules go far enough?
By Arthur Allen -
Florida’s New Covid Booster Guidance Is Straight-Up Misinformation
State Surgeon General Joseph Ladapo spread more anti-vaccine misinformation by telling Floridians to avoid mRNA vaccines. Vaccine experts and historians can’t remember another state health leader urging residents to avoid an FDA-approved vaccine.
-
The New Covid Vaccine Is Out. Why You Might Not Want To Rush To Get It.
Although public health officials recommend the newly approved covid vaccine for everyone 6 months and older, it may make more sense to wait until closer to the holiday season.
-
How Little Denmark Got Homegrown Giant Novo Nordisk To Lower Ozempic Prices
As Congress pushes for Medicare to cover payment for anti-obesity drugs, Denmark — Ozempic maker Novo Nordisk’s home — has limited coverage of the drug after cost overruns “emptied all the money boxes in the entire public health system.”
By Arthur Allen
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: